This page shows you the latest news items in this category. This is page number 7.

Total 45105 results found since Jan 2013.

Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults
The proposed concept encourages effectiveness research that will adapt, optimize and test empirically supported behavioral interventions designed to address common sleep problems in adolescents and young adults with a mental health disorder or who are at risk for developing a mental health disorder.
Source: National Institute of Mental Health - September 16, 2023 Category: Psychiatry Authors: National Institute of Mental Health Source Type: news

A New Bar Will Test Whether Mealworm Margaritas Sell in Singapore
Source: Reuters: Health - September 16, 2023 Category: Consumer Health News Source Type: news

How NASA Got a ‘ UFO Czar ’ —And Why it Matters
The real czars may be long gone, but for decades, the White House has been doing a good job of keeping the role—or at least the honorific—alive, appointing a director to oversee a particular task or issue, and bestowing the title along with it. We’ve had the Ebola Czar, the Drug Czar, the Budget Czar, the Climate Czar, and more. Yesterday, at a press conference at NASA’s Washington, D.C., headquarters, the space agency gave the old role a new look, appointing the country’s, and indeed the world’s, first-ever UFO Czar. Only NASA didn’t use either one of those terms. [time-brightcove...
Source: TIME: Science - September 15, 2023 Category: Science Authors: Jeffrey Kluger Tags: Uncategorized healthscienceclimate Source Type: news

Cisplatin Shortage Eases; Air Pollution Linked to Breast Cancer; Pap Test Confusion
(MedPage Today) -- The nation's supply of the widely used cancer drug cisplatin has almost returned to pre-shortage levels. (Becker's Hospital Review) The FDA announced a new and updated indication for temozolomide (Temodar) in anaplastic astrocytoma...
Source: MedPage Today Hematology/Oncology - September 15, 2023 Category: Hematology Source Type: news

Bitcoin Price Analysis: 26917 Target Tested Before Retreat
Bitcoin (BTC/USD) erased some recent gains early in the Asian session as the pair moderated after trading as high as the 26869.06 area, representing a test of an upside price objective around the 26917 area that is related to recent buying pressure around the 24900 and 25763.43 areas. Related…#btcusd #additionalstops #stops #hourly #technicalsupport #technicalresistance #macdaverage #sallyhostechnical #sallyhos #cryptodaily
Source: Reuters: Health - September 15, 2023 Category: Consumer Health News Source Type: news

Ethereum ’s Holešky testnet launch hits a speed bump
Ethereum’s Goerli testnet will soon come to an end following the launch of a new testnet, dubbed Holešky. Testnets are essentially copies of blockchains and exist for developers to test their protocols and smart contracts before deploying them onto the main blockchain. Today, there are two main…#ethereum #goerli #elholesky #holešky #parithoshjayanthi #ethereumfoundation #telegram
Source: Reuters: Health - September 15, 2023 Category: Consumer Health News Source Type: news

Take The Globe ’s business and investing news quiz
Welcome to The Globe and Mail’s business and investing news quiz. Join us each week to test your knowledge of the stories making the headlines. Our business reporters come up with the questions, and you can show us what you know. This week in business and investing: Canadians owe a staggering…#globeandmails #canadians #equifaxcanada #airbnb #shoplifting #sharonwhite #johnlewispartnership #primarkandwaitrose #rcmp #weathernetwork
Source: Reuters: Health - September 15, 2023 Category: Consumer Health News Source Type: news

Major Aussie bank takes next step to AUD stablecoin after Chainlink test transaction
Australia and New Zealand Banking Group is one step closer to launching its bank-issued stablecoin A$DC after the bank successfully executed a test transaction on Chainlink’s Cross-Chain Interoperability Protocol (CCIP): ANZ’s banking services portfolio lead Nigel Dobson said the transaction was a…#ccip #anz #nigeldobson #australian #blockchainaus
Source: Reuters: Health - September 15, 2023 Category: Consumer Health News Source Type: news

Doctors lost a man ' s ' likely cancerous ' tumor before they could test it. Now he ' s suing
Jeremy Morton-Maxson was already dealing with news no one wanted to hear. At the age of just 39, he had gone to doctors after experiencing painful urinary issues, which raised red flags for the carpenter who comes from a family with a history of bladder cancer. After waiting upward of five months…#jeremymortonmaxson #uwmedicine #seattle #mortonmaxson #seattletimes #austinneff #uwmedicinenorthwest #mychart #uw #wisconsin
Source: Reuters: Health - September 14, 2023 Category: Consumer Health News Source Type: news

Resolution Bioscience finds a buyer, averting shutdown
The deal comes weeks after parent company Agilent said it was shutting down the Kirkland-based cancer test maker.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 14, 2023 Category: Pharmaceuticals Authors: Rick Morgan Source Type: news

With the Decongestant SNAFU, the FDA Tries Something New
It’s easy to understand how a medicine like phenylephrine got onto pharmacy shelves in the first place. The common decongestant, used most often as an ingredient in multidrug cold medications like DayQuil and Sudafed PE, was initially designated as “safe and effective” by the Food and Drug Administration (FDA) in 1976, when the agency was newly—and less stringently than today—greenlighting drugs that had been on the market for years before the agency had established any efficacy standards. After a full review of 14 studies (12 unpublished and two published) from pharmaceutical companies—...
Source: TIME: Health - September 14, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized healthscienceclimate Source Type: news

U.S. cancels or curtails half of its Antarctic research projects
Marine biologist Michelle Shero had every reason to expect this to be a better year on the Antarctic ice. Since receiving a 5-year, $1.1 million grant from the National Science Foundation (NSF) in 2019 to study the reproductive success of Weddell seals in McMurdo Sound, Shero has been sent down for just one, truncated field season. But in January NSF had assured Shero that her team would be deployed in October for a full 4 months, and by June she had packed up and shipped out some $200,000 in equipment and supplies. So Shero, a tenure-track assistant scientist at the Woods Hole Oceanographic Institution, was stun...
Source: ScienceNOW - September 14, 2023 Category: Science Source Type: news

Exercise Stress Tests Can Also Predict Noncardiovascular Deaths
THURSDAY, Sept. 14, 2023 -- Abnormalities on an exercise stress test can predict both cardiovascular (CV)- and non-CV-related deaths, according to a study published in the September issue of Mayo Clinic Proceedings. N óra Sydó, M.D., Ph.D., from...
Source: Drugs.com - Pharma News - September 14, 2023 Category: Pharmaceuticals Source Type: news

Blood Test Accurately Diagnosed Celiac Disease in Adults
(MedPage Today) -- A blood test may be reliable in diagnosing some adults with suspected celiac disease, helping to avoid a biopsy, according to a prospective cohort study. In 436 adults with suspected disease and without IgA deficiency, a serum...
Source: MedPage Today Allergy - September 14, 2023 Category: Allergy & Immunology Source Type: news

GIFT ARTICLE: New top priority at Lake Nona ’s National SimVET Center: Testing tech
The National SimVET Center in Lake Nona is relaunching on Sept. 14 to celebrate its new mandate: test out technologies to see which ones will help providers give better care via the 1,000-plus Veterans Administration care sites around the nation. The relaunch event is from 10:00 a.m. to 3:00 p.m. at 13800 Veterans Way, Bldg. 13 Orlando, FL 32827. While SimVET will continue to offer simulated training experiences for frontline health care workers, “there was always a vision to do more testing and…
Source: bizjournals.com Health Care:Biotechnology headlines - September 14, 2023 Category: Biotechnology Authors: Sarah Kinbar Source Type: news